Iht Wealth Management, LLC Logic Bio Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $29,095 - $59,909	-13,225 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $1,251 - $1,654	-325 Reduced 2.4%	13,225 $61,000
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $9,228 - $17,335	2,290 Added 20.34%	13,550 $60,000
Q4 2020 Feb 17, 2021	SELL	$5.29 - $9.1 $1,058 - $1,820	-200 Reduced 1.75%	11,260 $86,000
Q3 2020 Nov 19, 2020	SELL	$5.41 - $9.45 $1,082 - $1,889	-200 Reduced 1.72%	11,460 $104,000
Q1 2020 May 13, 2020	BUY	$4.06 - $11.0 $47,339 - $128,260	11,660 New	11,660 $58,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.